Telix Pharmaceuticals welcomes Dr David Cade to the team - Sequoia Direct Pty Ltd

07OctOctober 7, 2019

Telix Pharmaceuticals welcomes Dr David Cade to the team

Telix Pharmaceuticals (ASX:TLX) today announced that Dr. David Cade has joined the Telix executive leadership team in the role of Chief Business Officer and Head of Investor Relations.

Telix is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on “molecularly-targeted radiation” (MTR), has

David brings over 20 years of significant commercial, clinical and public company experience to Telix. Notable prior executive roles include Chief Medical Officer at Cochlear and Sirtex, where his responsibilities included not only clinical strategy but also commercial and investorfacing aspects.

Shares in Telix Pharmaceuticals (ASX:TLX) closed 0.75 per cent higher on Friday.

Copyright 2019 – Finance News Network

Source: Finance News Network

Related Posts

02MarMarch 2, 2020

Corporate Travel Management (ASX:CTD) see a director step down

02 Mar 2020 - Corporate Travel Management (ASX:CTD) have announced the retirement of Admiral Robert J. Natter, US Navy (Ret.) from the Board, effective from today.

13JanJanuary 13, 2021

Newcrest Mining (ASX:NCM) approves funding for the Havieron Project

13 Jan 2021 - Newcrest Mining (ASX:NCM) has approved $146 million for the construction of the box cut, exploration decline and associated surface infrastructure at the Havieron Project in Western Australia.

14FebFebruary 14, 2020

Baby Bunting (ASX:BBN) increase dividend

14 Feb 2020 - Baby Bunting (ASX:BBN) has reported first half pro-forma sales of $186.4 million, with comparable sales up 1 per cent and total sales 8.1 per cent higher on the previous first half.

04DecDecember 4, 2020

Marley Spoon (ASX:MMM) CEO here to stay

04 Dec 2020 - Subscription-based meal kit provider Marley Spoon (ASX:MMM) has renewed its service agreement with CEO and founder Fabian Siegel.

19SepSeptember 19, 2021

Stocks of the Hour: Iress, Cimic & Medibank

17 Sep 2021 - A snapshot of stocks on the move, featuring Iress (ASX:IRE), Cimic (ASX:CIM) & Medibank (ASX:MPL).

26SepSeptember 26, 2019

Santos in another major Barossa contract award

26 Sep 2019 - Santos (ASX:STO) today announced the Barossa project has taken another big step towards a Final Investment Decision early next year with the award of the gas export pipeline contract.

07AugAugust 7, 2021

Stocks of the Hour: BWP Trust, GUD & ALE Property

04 Aug 2021 - A snapshot of some of the news that broke today featuring BWP Trust (ASX:BWP), GUD (ASX:GUD), ALE Property (ASX:LEP)

27JunJune 27, 2023

Stocks of the Hour: INOVIQ, Forrestania, Lincoln, Tamboran

27 Jun 2023 - A snapshot of the stocks on the move featuring INOVIQ, Forrestania Resources, Lincoln Minerals and Tamboran Resources.

17SepSeptember 17, 2020

Macmahon Holdings (ASX:MAH) is the preferred contractor for Warrawoona Gold Project

17 Sep 2020 - Macmahon Holdings (ASX:MAH) has been selected by Calidus Resources (ASX:CAI) as the preferred mining contractor for the Warrawoona gold project in Western Australia.

03DecDecember 3, 2020

Qantas (ASX:QAN) focusing on repair and recovery

03 Dec 2020 - Qantas (ASX:QAN) has started to repair its balance sheet as it sees Group Domestic capacity at 68 per cent of pre-COVID levels for December, rising to nearly 80 per cent for Quarter Three.